Clough Global Allocation Fund

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number: 811-21583

CLOUGH GLOBAL ALLOCATION FUND

(Exact name of registrant as specified in charter)

1290 Broadway, Suite 1100, Denver, Colorado 80203

(Address of principal executive offices) (Zip code)

Erin Nelson

Clough Global Allocation Fund

1290 Broadway, Suite 1100

Denver, Colorado 80203

(Name and address of agent for service)

Registrant’s telephone number, including area code: (303) 623-2577

Date of fiscal year end: March 31

Date of reporting period: December 31, 2013


Item 1 – Schedule of Investments.

The Schedule of Investments is included herewith.


Clough Global Allocation Fund
STATEMENT OF INVESTMENTS
December 31, 2013 (Unaudited)

 

     Shares     Value  

COMMON STOCKS 122.72%

   

Consumer Discretionary 31.98%

   

Asbury Automotive Group,
Inc.(a)(b)(c)

    41,404        $2,225,051   

AutoNation, Inc.(a)(b)(c)

    93,882        4,664,997   

Beazer Homes USA, Inc.(a)(b)

    60,371        1,474,260   

Byd Co., Ltd. - Class H(a)

    148,500        727,725   

Charter Communications, Inc. -
Class A(a)(b)(c)

    19,600        2,680,496   

Cia de Locacao das
Americas(d)

    161,639        479,590   

Denso Corp.

    14,500        764,172   

Don Quijote Co., Ltd.

    15,600        943,614   

DR Horton, Inc.(b)

    72,700        1,622,664   

Fifth & Pacific Cos., Inc.(a)(b)

    25,883        830,068   

Fuji Heavy Industries, Ltd.

    24,173        692,067   

Geely Automobile Holdings, Ltd.

    1,300,000        628,683   

Group 1 Automotive, Inc.(b)(c)

    33,389        2,371,287   

Honda Motor Co., Ltd.

    10,148        417,252   

Imax Corp.(a)(b)

    36,200        1,067,176   

Las Vegas Sands Corp.(b)

    7,675        605,327   

Lennar Corp. - Class A(b)

    45,500        1,799,980   

Liberty Global, Inc. -
Class A(a)(b)

    12,857        1,144,144   

Liberty Global, Inc. -
Series C(a)(b)

    18,400        1,551,488   

Liberty Interactive Corp. -
Class A(a)(b)

    63,651        1,868,157   

Liberty Media Corp. -
Class A(a)(b)(c)

    21,012        3,077,207   

Liberty Ventures -
Series A(a)(b)(c)

    34,186        4,190,862   

Lithia Motors, Inc. - Class A(b)(c)

    40,615        2,819,493   

Man Wah Holdings, Ltd.

    674,334        1,055,726   

Mazda Motor Corp.(a)

    136,757        706,446   

Orient-Express Hotels, Ltd. -
Class A(a)(b)

    45,406        686,085   

Penske Automotive Group,
Inc.(b)(c)

    64,341        3,034,322   

PulteGroup, Inc.(b)

    59,300        1,207,941   

Samsonite International S.A.

    268,800        818,086   

Service Corp. International(b)

    62,100        1,125,873   

Signet Jewelers, Ltd.

    7,500        590,250   

Sirius XM Holdings, Inc.(a)(b)

    474,600        1,656,354   

Time Warner Cable, Inc.(b)(c)

    21,020        2,848,210   

Toyota Motor Corp.

    19,700        1,200,969   

Under Armour, Inc. -
Class A(a)(b)

    14,500        1,265,850   

Wyndham Worldwide Corp.(b)(c)

    72,300        5,327,787   
   

 

 

 
      60,169,659   
   

 

 

 

Consumer Staples 2.79%

   

Brasil Pharma S.A.(a)(d)

    170,528        488,617   

China Huishan Dairy Holdings
Co., Ltd.(a)

    860,000        310,537   

 

    

 


     Shares     Value

Consumer Staples (continued)

   

Hengan International Group Co., Ltd.

    72,000      $850,522

Kirin Holdings Co., Ltd.

    72,000      1,034,432

Suntory Beverage & Food Ltd.

    10,600      337,698

Unicharm Corp.

    6,500      370,335

Vinda International Holdings, Ltd.

    601,498      1,000,648

Whole Foods Market, Inc.(b)

    14,700      850,101
   

 

    5,242,890
   

 

Energy 12.55%

   

Asia Oil Leveraged Exploration &
Production 1.07%

Gazprom OAO - ADR

    114,601      979,839

OAO Lukoil - Sponsored ADR

    16,614      1,037,544
   

 

    2,017,383
   

 

Natural Gas Leveraged Exploration &
Production 0.40%

Range Resources Corp.(b)

    9,000      758,790
   

 

Non-North American Producers 0.92%

InterOil Corp.(a)(b)

    33,419      1,720,744
   

 

Oil Leveraged Exploration & Production 3.18%

Anadarko Petroleum Corp.(b)

    8,906      706,424

Antero Resources Corp.(a)(b)

    2,700      171,288

Apache Corp.(b)

    8,300      713,302

Denbury Resources, Inc.(a)(b)

    45,912      754,334

EOG Resources, Inc.(b)

    2,000      335,680

Gulfport Energy Corp.(a)(b)

    20,108      1,269,820

Occidental Petroleum Corp.(b)

    9,200      874,920

Pioneer Natural Resources Co.(b)

    3,400      625,838

Talisman Energy, Inc.(b)

    45,900      534,735
   

 

    5,986,341
   

 

Oil Services & Drillers 1.02%

Dresser-Rand Group, Inc.(a)(b)

    9,900      590,337

Halliburton Co.(b)

    16,000      812,000

Weatherford International, Ltd.(a)(b)

    32,914      509,838
   

 

    1,912,175
   

 

Refiners 5.69%

   

HollyFrontier Corp.(b)

    48,698      2,419,804

Marathon Petroleum Corp.(b)

    27,700      2,540,921

Phillips 66(b)

    29,900      2,306,187

Tesoro Corp.

    15,200      889,200

Valero Energy Corp.(b)

    50,700      2,555,280
   

 

    10,711,392
   

 

 

    

 


     Shares     Value

Energy (continued)

   

Tankers 0.27%

Golar LNG, Ltd.(b)

    13,973      $507,080
   

 

TOTAL ENERGY

    23,613,905
   

 

Financials 24.07%

   

Capital Markets 4.82%

CITIC Securities Co., Ltd. - Class H

    549,797      1,499,582

Daiwa Securities Group, Inc.

    266,105      2,653,217

Haitong Securities Co., Ltd. -
Class H(d)

    735,253      1,280,053

Morgan Stanley(b)(c)

    95,287      2,988,200

Nomura Holdings, Inc.

    84,600      649,904
   

 

    9,070,956
   

 

Commercial Banks 3.87%

Grupo Financiero Banorte SAB de
CV - Class O

    105,888      740,928

Mitsubishi UFJ Financial Group, Inc.

    155,400      1,024,096

Mizuho Financial Group, Inc.

    473,100      1,024,279

Sberbank of Russia - ADR

    42,010      528,486

Sumitomo Mitsui Financial Group, Inc.

    21,800      1,121,983

Sumitomo Mitsui Trust Holdings, Inc.

    277,500      1,459,833

Wells Fargo & Co.

    30,500      1,384,700
   

 

    7,284,305
   

 

Diversified Financials 7.04%

Atlas Mara Co.-Nvest, Ltd.(a)(d)

    116,958      1,412,268

Bank of America Corp.(b)(c)

    197,091      3,068,707

Citigroup, Inc.(b)(c)

    133,028      6,932,089

ING Groep NV(a)

    65,589      911,334

JPMorgan Chase & Co.(b)

    15,700      918,136
   

 

    13,242,534
   

 

Insurance 2.68%

American International Group, Inc.

    21,712      1,108,398

Genworth Financial, Inc. -
Class A(a)(b)(c)

    131,861      2,047,801

Hartford Financial Services Group, Inc.(b)

    51,928      1,881,351
   

 

    5,037,550
   

 

Real Estate Investment Trusts 3.41%

American Homes 4 Rent -
Class A(a)(d)(e)

    109,600      1,775,520

American Residential Properties, Inc.(a)(b)(d)

    34,000      583,440

Digital Realty Trust, Inc.(b)

    23,867      1,172,347

PennyMac Mortgage Investment Trust(b)

    40,600      932,176

    

 


     Shares     Value

Financials (continued)

   

Redwood Trust, Inc.(b)

    40,100      $776,737

Select Income REIT(d)

    18,300      489,342

Two Harbors Investment Corp.

    74,100      687,648
   

 

    6,417,210
   

 

Real Estate Management & Development 0.26%

BHG S.A. - Brazil Hospitality
Group(a)

    84,200      492,513
   

 

Thrifts & Mortgage Finance 1.99%

Home Loan Servicing Solutions Ltd.(b)

    45,592      1,047,248

Nationstar Mortgage Holdings,
Inc.(a)(b)(c)

    22,850      844,536

Ocwen Financial Corp.(a)(b)

    33,300      1,846,485
   

 

    3,738,269
   

 

TOTAL FINANCIALS

    45,283,337
   

 

Health Care 19.87%

   

Aetna, Inc.(b)(c)

    25,751      1,766,261

Akorn, Inc.(a)(b)

    64,800      1,596,024

Alkermes PLC(a)(b)

    20,800      845,728

Allergan, Inc.(b)(c)

    20,500      2,277,140

Amarin Corp. PLC - ADR(a)

    55,242      108,827

Astellas Pharma, Inc.

    22,900      1,354,734

Biogen Idec, Inc.(a)(b)

    4,600      1,286,850

Catamaran Corp.(a)(b)(c)

    49,600      2,355,008

Celgene Corp.(a)(b)(c)

    12,051      2,036,137

Centene Corp.(a)

    11,800      695,610

Community Health Systems,
Inc.(a)(b)

    19,806      777,782

Forest Laboratories, Inc.(a)(b)(c)

    38,929      2,336,908

Gilead Sciences, Inc.(a)(b)(c)

    25,995      1,953,524

HCA Holdings, Inc.(a)(b)

    33,877      1,616,272

Healthways, Inc.(a)(b)

    92,498      1,419,844

Ironwood Pharmaceuticals, Inc.(a)(b)

    55,000      638,550

Jazz Pharmaceuticals PLC(a)

    5,413      685,069

LifePoint Hospitals, Inc.(a)(b)

    19,690      1,040,419

McKesson Corp.(b)

    6,380      1,029,732

Perrigo Co. Plc(b)

    10,900      1,672,714

Pfizer, Inc.(b)(c)

    98,800      3,026,244

Salix Pharmaceuticals, Ltd.(a)(b)

    7,700      692,538

Sanofi - ADR(b)

    17,153      919,915

Sinopharm Group Co., Ltd. -
Class H

    396,400      1,137,420

Team Health Holdings, Inc.(a)(b)

    16,734      762,234

Towa Pharmaceutical Co., Ltd.

    14,000      586,934

UnitedHealth Group, Inc.(b)

    9,400      707,820

Veracyte, Inc.(a)(b)

    7,700      111,650

    

 


     Shares     Value

Health Care (continued)

   

WellPoint, Inc.(b)(c)

    21,200      $1,958,668
   

 

    37,396,556
   

 

Industrials 14.06%

   

Allison Transmission Holdings,
Inc.(b)(c)(d)

    132,569      3,660,230

Brenntag AG

    9,288      1,721,775

Colfax Corp.(a)(b)

    13,614      867,076

Delta Air Lines, Inc.

    101,000      2,774,470

Empresas ICA SAB de CV(a)

    241,609      498,707

Empresas ICA SAB de CV -
ADR(a)(b)(c)

    15,930      134,609

FANUC Corp.

    4,100      749,454

FLIR Systems, Inc.(b)

    97,000      2,919,700

Japan Airlines Co., Ltd.

    17,300      852,597

Mitsubishi Heavy Industries, Ltd.

    182,000      1,125,078

Scorpio Bulkers, Inc.(a)

    30,700      308,535

SMC Corp.

    1,840      463,014

Sumitomo Corp.

    37,672      472,554

TransDigm Group, Inc.(b)

    10,400      1,674,608

United Continental Holdings, Inc.(a)

    66,900      2,530,827

Verisk Analytics, Inc. - Class A(a)(b)

    13,400      880,648

ViaSat, Inc.(a)(b)(c)

    47,949      3,004,005

WABCO Holdings, Inc.(a)(b)

    13,545      1,265,238

Wesco Aircraft Holdings, Inc.(a)

    24,900      545,808
   

 

    26,448,933
   

 

Information Technology 14.25%

   

Cisco Systems, Inc.(b)

    76,900      1,726,405

Citrix Systems, Inc.(a)(b)

    23,900      1,511,675

eBay, Inc.(a)(b)

    29,707      1,630,617

EMC Corp.(b)

    37,100      933,065

Endurance International Group Holdings, Inc.(a)(b)

    110,100      1,561,218

Google, Inc. - Class A(a)

    4,040      4,527,669

Hoya Corp.

    13,400      371,805

Investment AB Kinnevik - Class B

    50,178      2,324,063

Jive Software, Inc.(a)(b)

    73,835      830,644

Keyence Corp.

    1,450      619,599

Micron Technology, Inc.(a)(b)(c)

    85,000      1,849,600

NXP Semiconductor NV(a)(b)

    40,152      1,844,181

Omron Corp.

    22,597      996,706

Samsung Electronics Co., Ltd.

    553      718,924

SanDisk Corp.(b)

    27,134      1,914,032

Seagate Technology(b)

    24,900      1,398,384

SK Hynix, Inc.(a)

    27,911      973,255

Western Digital Corp.(b)

    12,900      1,082,310
   

 

    26,814,152
   

 

    

 


     Shares     Value

Materials 2.88%

   

Berry Plastics Group, Inc.(a)(b)

    72,801      $1,731,936

Graphic Packaging Holding Co.(a)(b)

    153,406      1,472,697

WR Grace & Co.(a)(b)

    22,500      2,224,575
   

 

    5,429,208
   

 

Telecommunication Services 0.27%

Nippon Telegraph & Telephone Corp.

    9,500      510,588
   

 

TOTAL COMMON STOCKS

(Cost $200,319,390)

    230,909,228
   

 

EXCHANGE TRADED FUNDS 1.73%

  

 

SPDR® Gold Shares(a)(b)

    27,970      3,249,275
   

 

TOTAL EXCHANGE TRADED FUNDS

(Cost $3,611,498)

  

  

  3,249,275
   

 

PREFERRED STOCKS 1.19%

   

Financials 0.40%

First Republic Bank, 5.500%(b)

    38,600      744,980
   

 

Fixed Income 0.79%

BB&T Corp., Series G,
5.200%(b)

    38,600      725,680

US Bancorp, Series H,
5.150%(b)

    38,600      770,842
   

 

    1,496,522
   

 

TOTAL PREFERRED STOCKS

(Cost $2,898,474)

  

  

  2,241,502
   

 

WARRANTS 0.04%

   

Atlas Mara Co.-Nvest, Ltd., Strike price $11.50, Expires 12/17/2017(a)

    116,958      74,853
   

 

TOTAL WARRANTS

(Cost $1,170)

    74,853
   

 

Description and

Maturity Date

  Principal  
Amount
    Value

CORPORATE BONDS 8.94%

   

B/E Aerospace, Inc.
04/01/2022, 5.250% (b)

    $575,000      586,500

Ball Corp.
11/15/2023, 4.000% (b)

    1,025,000      922,500

Bank of America Corp.
Series U, 12/01/2049, 5.200%(b)(f)

    1,665,000      1,473,525

    

 


Description and

Maturity Date

  Principal  
Amount
    Value

CORPORATE BONDS (continued)

The Bank of New York Mellon Corp.
Series D, 12/20/2049, 4.500%(b)(f)

    $1,190,000     

$1,082,900

Citigroup, Inc.
07/30/2049, 5.950% (b)(f)

    1,335,000     

1,237,011

Crown Americas LLC / Crown Americas Capital Corp. IV
Series WI, 01/15/2023, 4.500%(b)

    1,050,000     

987,000

Eaton Vance Corp.
06/15/2023, 3.625% (b)

    490,000     

469,632

Ford Motor Credit Co. LLC
09/20/2022, 4.250% (b)

    1,000,000     

1,004,921

General Electric Capital Corp.
Series C, 06/15/2049, 5.250%(b)(f)

    1,050,000     

989,625

General Motors Co.
10/02/2023, 4.875% (b)(d)

    1,500,000     

1,526,250

ING US, Inc.
05/15/2053, 5.650% (b)(f)

    150,000     

145,912

JPMorgan Chase & Co.
Series Q, 11/01/2049, 5.150%(b)(f)

    1,485,000     

1,340,212

Lamar Media Corp.
05/01/2023, 5.000% (b)

    740,000     

706,700

Lear Corp.
01/15/2023, 4.750% (b)(d)

    725,000     

683,313

PNC Financial Services Group, Inc.,
Series R, 05/29/2049, 4.850%(b)(f)

    1,490,000     

1,338,020

Provident Bank of Maryland
05/01/2018, 9.500% (b)

    1,000,000     

997,223

TRW Automotive, Inc.
12/01/2023, 4.450% (d)

    435,000     

423,038

Zions Bancorporation
12/15/2049, 5.800% (b)(f)

    1,005,000     

917,063

   

 

TOTAL CORPORATE BONDS

(Cost $16,919,872)

    16,831,345
   

 

ASSET/MORTGAGE BACKED SECURITIES 0.19%

Small Business Administration Participation Certificates
Series 2008-20L, Class 1,
12/01/2028, 6.220%(b)

    321,901      363,393
   

 

TOTAL ASSET/MORTGAGE BACKED SECURITIES

(Cost $321,902)

   

  

  363,393
   

 

GOVERNMENT & AGENCY OBLIGATIONS 5.93%

U.S. Treasury Bonds

   

05/15/2021, 3.125% (b)

    3,200,000      3,332,000

11/15/2023, 2.750% (b)

    3,400,000      3,320,579

08/15/2029, 6.125% (b)

    1,245,000      1,631,728

08/15/2041, 3.750% (b)

    2,950,000      2,865,188
   

 

TOTAL GOVERNMENT & AGENCY OBLIGATIONS

(Cost $11,435,224)

   

  

  11,149,495
   

 

    

 


     Number of
Contracts
    Value

PURCHASED OPTIONS

   

PUT OPTIONS PURCHASED 0.27%

S&P 500® Index, Expires February, 2014, Exercise Price $1,800.00

    300      $516,000
   

 

TOTAL PURCHASED OPTIONS

(Cost $855,610)

  

  

  516,000
   

 

     Shares     Value

SHORT-TERM INVESTMENTS 6.64%

Money Market Fund

   

Morgan Stanley Institutional Liquidity Funds - Prime Portfolio
(0.045% 7-day yield)

    12,484,637      12,484,637
   

 

TOTAL SHORT-TERM INVESTMENTS

(Cost $12,484,637)

  

  

 

12,484,637

   

 

Total Investments - 147.65%

(Cost $248,847,777)

  

  

 

277,819,728

Liabilities in Excess of Other Assets - (47.65%)(g)

   

  (89,659,446)
   

 

NET ASSETS - 100.00%

    $188,160,282
   

 

SCHEDULE OF WRITTEN

OPTIONS

  Number of
Contracts
    Value

CALL OPTIONS WRITTEN

McKesson Corp., Expires January, 2014, Exercise Price $140.00

    30      $(63,900)

Pfizer, Inc., Expires March, 2014, Exercise Price $30.00

    500      (58,500)
   

 

TOTAL CALL OPTIONS WRITTEN

(Premiums received $38,148)

  

  

  (122,400)
   

 

PUT OPTIONS WRITTEN

   

S&P 500® Index, Expires February, 2014, Exercise Price $1,720.00

    300      (202,500)
   

 

TOTAL PUT OPTIONS WRITTEN

(Premiums received $343,391)

  

  

 

(202,500)

   

 

TOTAL WRITTEN OPTIONS

(Premiums received $381,539)

  

  

 

$(324,900)

   

 

    

 


SCHEDULE OF SECURITIES SOLD

SHORT (a)

  Shares     Value

COMMON STOCKS (15.15%)

   

Energy (0.51%)

   

Non-North American Producers (0.51%)

Petroleo Brasileiro S.A. - ADR

    (69,519   $(957,972)
   

 

TOTAL ENERGY

    (957,972)
   

 

Financials (2.54%)

   

Capital Markets (0.83%)

Deutsche Bank AG

    (25,739   (1,241,649)

Mediobanca SpA

    (35,800   (313,232)
   

 

    (1,554,881)
   

 

Commercial Banks (1.71%)

Banco Bilbao Vizcaya Argentaria S.A. - ADR

    (7,771   (96,283)

Banco Santander S.A.

    (64,331   (575,784)

Banco Santander S.A. - ADR

    (10,358   (93,947)

Credit Agricole S.A.

    (35,715   (457,185)

Lloyds Banking Group PLC

    (600,006   (783,740)

Societe Generale S.A.

    (18,477   (1,073,186)

UniCredit SpA

    (18,961   (140,336)
   

 

    (3,220,461)
   

 

TOTAL

FINANCIALS

    (4,775,342)
   

 

Health Care (2.96%)

   

Intuitive Surgical, Inc.

    (2,743   (1,053,531)

Merck & Co., Inc.

    (34,500   (1,726,725)

Owens & Minor, Inc.

    (18,700   (683,672)

St. Jude Medical, Inc.

    (11,800   (731,010)

Vertex Pharmaceuticals, Inc.

    (9,480   (704,364)

Waters Corp.

    (6,800   (680,000)
   

 

    (5,579,302)
   

 

Industrials (3.39%)

   

Atlas Copco AB - A Shares

    (55,752   (1,545,524)

Bombardier, Inc. - Class B

    (270,983   (1,176,024)

Caterpillar, Inc.

    (24,000   (2,179,440)

Sandvik AB

    (104,789   (1,477,703)
   

 

    (6,378,691)
   

 

Information Technology (4.38%)

   

Arrow Electronics, Inc.

    (3,800   (206,150)

ASML Holding NV

    (14,900   (1,396,130)

Avago Technologies, Ltd.

    (21,000   (1,110,690)

F5 Networks, Inc.

    (16,777   (1,524,358)

Freescale Semiconductor, Ltd.

    (44,200   (709,410)

Hewlett-Packard Co.

    (52,803   (1,477,428)

Infosys Technologies, Ltd. - Sponsored ADR

    (1,218   (68,939)

    

 


SCHEDULE OF SECURITIES

SOLD SHORT (a)

  Shares     Value

Information Technology (continued)

International Business Machines Corp.

    (5,500   $(1,031,635)

Xilinx, Inc.

    (15,500   (711,760)
   

 

    (8,236,500)
   

 

Materials (1.37%)

   

BHP Billiton, Ltd.

    (27,839   (944,331)

Cliffs Natural Resources, Inc.

    (62,534   (1,639,016)
   

 

    (2,583,347)
   

 

TOTAL COMMON STOCKS

(Proceeds $26,214,051)

  

  

 

(28,511,154)

   

 

EXCHANGE TRADED FUNDS (20.93%)

Health Care Select Sector SPDR® Fund

    (69,800   (3,869,712)

iShares® FTSE China 25 Index Fund

    (44,493   (1,706,307)

iShares® MSCI Emerging Markets Index Fund

    (90,600   (3,784,362)

iShares® Nasdaq Biotechnology ETF

    (8,687   (1,972,470)

iShares® Russell 2000® Index Fund

    (162,800   (18,772,468)

SPDR® S&P 500® ETF Trust

    (50,200   (9,270,434)

TOTAL EXCHANGE TRADED FUNDS

(Proceeds $34,909,327)

  

  

 

(39,375,753)

   

 

TOTAL SECURITIES SOLD SHORT

(Proceeds $61,123,378)

  

  

 

$(67,886,907)

   

 

    

 

 

(a)  Non-income producing security.
(b) Pledged security; a portion or all of the security is pledged as collateral for written options, securities sold short or borrowings as of December 31, 2013. (See Note 1)
(c) Loaned security; a portion or all of the security is on loan as of December 31, 2013.
(d) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. As of December 31, 2013, these securities had a total value of $12,801,661 or 6.80% of net assets.
(e) Fair valued security; valued by management in accordance with procedures approved by the Fund’s Board of Trustees. As of December 31, 2013, these securities had a total value of $1,775,520 or 0.94% of total net assets.
(f)  Floating or variable rate security - rate disclosed as of December 31, 2013.
(g) Includes cash which is being held as collateral for total return swap contracts.

Abbreviations:

AB - Aktiebolag is the Swedish equivalent of the term corporation

ADR - American Depositary Receipt

AG - Aktiengesellschaft is a German term that refers to a corporation that is limited by shares, i.e., owned by shareholders

Bps - Basis Points

ETF - Exchange Traded Fund

LLC - Limited Liability Corporation

Ltd. - Limited

MSCI - Morgan Stanley Capital International

NV - Naamloze Vennootschap (Dutch: Limited Liability Company)

OAO - Otkrytoe Aktsionernoe Obschestvo (a Russian open joint stock corporation)

PLC - Public Limited Liability


REIT - Real Estate Investment Trust

S.A. - Generally designates corporations in various countries, mostly those employing the civil law

SpA - Societa` Per Azioni is an Italian shared company

SAB de CV - Sociedad Anonima de Capital Variable (Spanish Variable Capital Company)

S&P - Standard & Poor’s

SPDR - Standard & Poor’s Depositary Receipt

 

TOTAL RETURN SWAP CONTRACTS            
Counter Party   

Reference

Entry/Obligation

   Notional
Amount
     Floating Rate Paid by the
Fund
   Floating Rate Index    Termination
Date
    

Unrealized

Depreciation

 

Morgan Stanley

   Bharti Infratel, Ltd.    $     1,535,035       30 Bps + 1D FEDEF    1D FEDEF      12/30/2014       $ (498,932)   
     

 

 

             

 

 

 
      $     1,535,035                $ (498,932)   
     

 

 

             

 

 

 

 

INCOME TAX INFORMATION

 

    

Net unrealized appreciation/depreciation of investments based on federal tax costs were as follows:

  
         As of December 31, 2013      

Gross appreciation (excess of value over tax cost)

           $ 33,579,011   

Gross depreciation (excess of tax cost over value)

     (5,819,879)   

Net unrealized appreciation

           $ 27,759,132   
  

 

 

 

Cost of investments for income tax purposes

           $ 250,060,596   
  

 

 

 

See Notes to Quarterly Statement of Investments.


CLOUGH GLOBAL ALLOCATION FUND

NOTES TO QUARTERLY STATEMENT OF INVESTMENTS

DECEMBER 31, 2013 (UNAUDITED)

1. ORGANIZATION AND SIGNIFICANT ACCOUNTING AND OPERATING POLICIES

 

Clough Global Allocation Fund (the “Fund”) is a closed-end management investment company that was organized under the laws of the state of Delaware by an Amended Agreement and Declaration of Trust dated April 27, 2004. The Fund is a non-diversified series with an investment objective to provide a high level of total return. The Declaration of Trust provides that the Trustees may authorize separate classes of shares of beneficial interest.

The net asset value per share of the Fund is determined no less frequently than daily, on each day that the New York Stock Exchange (the “Exchange”) is open for trading, as of the close of regular trading on the Exchange (normally 4:00 p.m. New York time). Trading may take place in foreign issues held by the Fund at times when the Fund is not open for business. As a result, the Fund’s net asset value may change at times when it is not possible to purchase or sell shares of the Fund.

Investment Valuation: Securities held by the Fund for which exchange quotations are readily available are valued at the last sale price, or if no sale price or if traded on the over-the-counter market, at the mean of the bid and asked prices on such day. Most securities listed on a foreign exchange are valued at the last sale price at the close of the exchange on which the security is primarily traded. In certain countries market maker prices are used since they are the most representative of the daily trading activity. Market maker prices are usually the mean between the bid and ask prices. Certain markets are not closed at the time that the Fund prices its portfolio securities. In these situations, snapshot prices are provided by the individual pricing services or other alternate sources at the close of the NYSE as appropriate. Securities not traded on a particular day are valued at the mean between the last reported bid and the asked quotes, or the last sale price when appropriate; otherwise fair value will be determined by the board-appointed fair valuation committee. Debt securities for which the over-the-counter market is the primary market are normally valued on the basis of prices furnished by one or more pricing services or dealers at the mean between the latest available bid and asked prices. As authorized by the Trustees, debt securities (other than short-term obligations) may be valued on the basis of valuations furnished by a pricing service which determines valuations based upon market transactions for normal, institutional-size trading units of securities or a matrix method which considers yield or price of comparable bonds provided by a pricing service. Short-term obligations maturing within 60 days are valued at amortized cost, which approximates value, unless the Trustees determine that under particular circumstances such method does not result in fair value. Over-the-counter options are valued at the mean between bid and asked prices provided by dealers. Financial futures contracts listed on commodity exchanges and exchange-traded options are valued at closing settlement prices. Total return swaps are priced based on valuations provided by a board approved independent third party pricing agent. If a total return swap price cannot be obtained from an independent third party pricing agent the Fund shall seek to obtain a bid price from at least one independent and/or executing broker.

If the price of a security is unavailable in accordance with the aforementioned pricing procedures, or the price of a security is unreliable, e.g., due to the occurrence of a significant event, the security may be valued at its fair value determined by management pursuant to procedures adopted by the Board of Trustees. For this purpose, fair value is the price that the Fund reasonably expects to receive on a current sale of the security. Due to the number of variables affecting the price of a security, however; it is possible that the fair value of a security may not accurately reflect the price that a Fund could actually receive on a sale of the security.

A three-tier hierarchy has been established to classify fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability that are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability that are developed based on the best information available.

Various inputs are used in determining the value of the Fund’s investments as of the reporting period end. These inputs are categorized in the following hierarchy under applicable financial accounting standards:

 

Level 1 –

 

Unadjusted quoted prices in active markets for identical, unrestricted assets or liabilities that the Fund has the ability to access at the measurement date;

Level 2 –

 

Quoted prices which are not active, quoted prices for similar assets or liabilities in active markets or inputs other than quoted prices that are observable (either directly or indirectly) for substantially the full term of the asset or liability; and

Level 3 –

 

Significant unobservable prices or inputs (including the Fund’s own assumptions in determining the fair value of investments) where there is little or no market activity for the asset or liability at the measurement date.


The following is a summary of the inputs used as of December 31, 2013 in valuing the Fund’s investments carried at value. The Fund recognizes transfers between the levels as of the beginning of the annual period in which the transfer occurred. There were no transfers between Levels 1 and 2 during the period ended December 31, 2013:

 

Investments in Securities at Value*    Level 1      Level 2      Level 3      Total  

Assets

           

Common Stocks

           

Consumer Discretionary

   $ 60,169,659      $  –      $      $ 60,169,659  

Consumer Staples

     5,242,890                      5,242,890  

Energy

     23,613,905                      23,613,905  

Financials

     43,507,817        1,775,520               45,283,337  

Health Care

     37,396,556                      37,396,556  

Industrials

     26,448,933                      26,448,933  

Information Technology

     26,814,152                      26,814,152  

Materials

     5,429,208                      5,429,208  

Telecommunication Services

     510,588                      510,588  

Exchange Traded Funds

     3,249,275                      3,249,275  

Preferred Stocks

     2,241,502                      2,241,502  

Warrants

     74,853                      74,853  

Corporate Bonds

            16,831,345               16,831,345  

Asset/Mortgage Backed Securities

            363,393               363,393  

Government & Agency Obligations

     11,149,495                      11,149,495  

Purchased Options

     516,000                      516,000  

Short-Term Investments

     12,484,637                      12,484,637  

 

 

TOTAL

   $     258,849,470      $     18,970,258      $      $     277,819,728  

 

 

Other Financial Instruments

           

 

 

Liabilities

           

Written Options

   $ (324,900)      $      $      $ (324,900)  

Securities Sold Short

           

Common Stocks

   $ (28,511,154)      $      $      $ (28,511,154)  

Exchange Traded Funds

     (39,375,753)                      (39,375,753)  

Total Return Swap Contracts**

   $  –      $ (498,932)      $      $ (498,932)  

 

 

TOTAL

   $ (68,211,807)      $ (498,932)      $      $ (68,710,739)  

 

 

 

*       For detailed industry descriptions, see the accompanying Statements of Investments.

**     Swap contracts are reported at their unrealized appreciation/(depreciation) at measurement date, which represents the change in the contract’s value from trade date.

In the event a board approved independent pricing service is unable to provide an evaluated price for a security or Clough Capital Partners L.P. (the “advisor”) believes the price provided is not reliable, securities of the Fund may be valued at fair value as described above. In these instances the advisor may seek to find an alternative independent source, such as a broker/dealer to provide a price quote, or by using evaluated pricing models similar to the techniques and models used by the independent pricing service. These fair value measurement techniques may utilize unobservable inputs (Level 3).

On a monthly basis, the Fair Value Committee of the Fund meets and discusses securities that have been fair valued during the preceding month in accordance with the Fund’s Fair Value Procedures and reports quarterly to the Board of Trustees on the results of those meetings.

For the period ended December 31, 2013, the Fund did not have significant unobservable inputs (Level 3) used in determining fair value. Therefore, a reconciliation of assets in which significant unobservable inputs (Level 3) were used in determining fair value is not applicable.

Foreign Securities: The Fund may invest a portion of its assets in foreign securities. In the event that the Fund executes a foreign security transaction, the Fund will generally enter into a forward foreign currency contract to settle the foreign security transaction. Foreign securities may carry more risk than U.S. securities, such as political, market and currency risks.

The accounting records of the Fund are maintained in U.S. dollars. Prices of securities denominated in foreign currencies are translated into U.S. dollars at the closing rates of exchange at period end. Amounts related to the purchase and sale of foreign securities and investment income are translated at the rates of exchange prevailing on the respective dates of such transactions.


A foreign currency contract is a commitment to purchase or sell a foreign currency at a future date, at a negotiated rate. The Fund may enter into foreign currency contracts to settle specific purchases or sales of securities denominated in a foreign currency and for protection from adverse exchange rate fluctuation. Risks to the Fund include the potential inability of the counterparty to meet the terms of the contract.

The net U.S. dollar value of foreign currency underlying all contractual commitments held by the Fund and the resulting unrealized appreciation or depreciation are determined using prevailing forward foreign currency exchange rates. These spot contracts are used by the broker to settle investments denominated in foreign currencies.

Short Sales: The Fund may sell a security it does not own in anticipation of a decline in the fair value of that security. When the Fund sells a security short, it must borrow the security sold short and deliver it to the broker-dealer through which it made the short sale. A gain, limited to the price at which the Fund sold the security short, or a loss, unlimited in size, will be recognized upon the termination of the short sale.

The Fund may also sell a security short if it owns at least an equal amount of the security sold short or another security convertible or exchangeable for an equal amount of the security sold short without payment of further compensation (a short sale against-the-box). In a short sale against-the-box, the short seller is exposed to the risk of being forced to deliver stock that it holds to close the position if the borrowed stock is called in by the lender, which would cause gain or loss to be recognized on the delivered stock. The Fund expects normally to close its short sales against-the-box by delivering newly acquired stock.

Derivatives Instruments and Hedging Activities: The following discloses the Fund’s use of derivative instruments and hedging activities.

The Fund’s investment objectives not only permit the Fund to purchase investment securities, they also allow the Fund to enter into various types of derivative contracts, including, but not limited to, purchased and written options, swaps, and warrants. In doing so, the Fund will employ strategies in differing combinations to permit it to increase, decrease, or change the level or types of exposure to market factors. Central to those strategies are features inherent to derivatives that make them more attractive for this purpose than equity securities; they require little or no initial cash investment, they can focus exposure on only certain selected risk factors, and they may not require the ultimate receipt or delivery of the underlying security (or securities) to the contract. This may allow the Fund to pursue its objective more quickly and efficiently than if it was to make direct purchases or sales of securities capable of effecting a similar response to market factors.

Market Risk Factors: In pursuit of its investment objective, the Fund may seek to use derivatives to increase or decrease its exposure to the following market risk factors:

Equity Risk: Equity risk relates to the change in value of equity securities as they relate to increases or decreases in the general market.

Risk of Investing in Derivatives: The Fund’s use of derivatives can result in losses due to unanticipated changes in the market risk factors and the overall market. In instances where the Fund is using derivatives to decrease or hedge exposures to market risk factors for securities held by the Fund, there are also risks that those derivatives may not perform as expected, resulting in losses for the combined or hedged positions.

Derivatives may have little or no initial cash investment relative to their market value exposure and therefore can produce significant gains or losses in excess of their cost. This use of embedded leverage allows the Fund to increase its market value exposure relative to its net assets and can substantially increase the volatility of the Fund’s performance.

Additional associated risks from investing in derivatives also exist and potentially could have significant effects on the valuation of the derivative and the Fund. Typically, the associated risks are not the risks that the Fund is attempting to increase or decrease exposure to, per its investment objective, but are the additional risks from investing in derivatives.

Examples of these associated risks are liquidity risk, which is the risk that the Fund will not be able to sell the derivative in the open market in a timely manner, and counterparty credit risk, which is the risk that the counterparty will not fulfill its obligation to the Fund. Associated risks can be different for each type of derivative and are discussed by each derivative type in the notes that follow.

The Fund may acquire put and call options and options on stock indices and enter into stock index futures contracts, certain credit derivatives transactions and short sales in connection with its equity investments. In connection with the Fund’s investments in debt securities, it may enter into related derivatives transactions such as interest rate futures, swaps and options thereon and certain credit derivatives transactions. Derivatives transactions of the types described above subject the Fund to increased risk of principal loss due to imperfect correlation or unexpected price or interest rate movements. The Fund also will be subject to credit risk with respect to the counterparties to the derivatives contracts purchased by a Fund. If a counterparty becomes bankrupt or otherwise fails to perform its obligations under a derivatives contract due to financial difficulties, the Fund may experience significant delays in obtaining any recovery under the derivatives contract in a bankruptcy or other reorganization proceeding. The Fund may obtain only a limited recovery or may obtain no recovery in such circumstances.


Option Writing/Purchasing: The Fund may purchase or write (sell) put and call options. One of the risks associated with purchasing an option among others, is that the Fund pays a premium whether or not the option is exercised. Additionally, the Fund bears the risk of loss of premium and change in market value should the counterparty not perform under the contract. The cost of securities acquired through the exercise of call options is increased by premiums paid. The proceeds from securities sold through the exercise of put options are decreased by the premiums paid. The Fund is obligated to pay interest to the broker for any debit balance of the margin account relating to options.

When the Fund writes an option, an amount equal to the premium received by the Fund is recorded as a liability and is subsequently adjusted to the current value of the option written. Premiums received from writing options that expire unexercised are treated by the Fund on the expiration date as realized gains. The difference between the premium received and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is recorded as a realized gain or loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Fund has realized a gain or loss. If a put option is exercised, the premium reduces the cost basis of the securities purchased by the Fund. The Fund, as writer of an option, bears the market risk of an unfavorable change in the price of the security underlying the written option.

 

      Written Call Options      Written Put Options  
      Contracts      Premiums      Contracts      Premiums  

Outstanding, March 31, 2013

           $               $   

Positions opened

     2,427         265,225         1,200         1,574,559   

Exercised

                               

Expired

                               

Closed

     (1,897)         (227,077)         (900)         (1,231,168)   

Split

                               

 

 

Outstanding, December 31, 2013

     530       $ 38,148         300       $ 343,391   

 

 

Market Value, December 31, 2013

      $ 122,400          $ 202,500   

 

 

Swaps: During the period the Fund engaged in total return swaps. A swap is an agreement that obligates two parties to exchange a series of cash flows at specified intervals based upon or calculated by reference to changes in specified prices or rates for a specified amount of an underlying asset. The Fund may utilize swap agreements as a means to gain exposure to certain assets and/or to “hedge” or protect the Fund from adverse movements in securities prices or interest rates. The Fund is subject to equity risk and interest rate risk in the normal course of pursuing its investment objective through investments in swap contracts. Swap agreements entail the risk that a party will default on its payment obligation to the Fund. If the other party to a swap defaults, the Fund would risk the loss of the net amount of the payments that it contractually is entitled to receive. If the Fund utilizes a swap at the wrong time or judges market conditions incorrectly, the swap may result in a loss to the Fund and reduce the Fund’s total return.

Total return swaps involve an exchange by two parties in which one party makes payments based on a set rate, either fixed or variable, while the other party makes payments based on the return of an underlying asset, which includes both the income it generates and any capital gains over the payment period. The Fund’s maximum risk of loss from counterparty risk or credit risk is the discounted value of the payments to be received from/paid to the counterparty over the contract’s remaining life, to the extent that the amount is positive. The risk is mitigated by having a netting arrangement between the Fund and the counterparty and by the posting of collateral to the Fund to cover the Fund’s exposure to the counterparty.

International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Master Agreements”) govern OTC financial derivative transactions entered into by a Fund and those counterparties. The ISDA Master Agreements maintain provisions for general obligations, representations, agreements, collateral and events of default or termination. Events of termination include conditions that may entitle counterparties to elect to terminate early and cause settlement of all outstanding transactions under the applicable ISDA Master Agreement. Any election to early terminate could be material to the financial statements.

During the nine month period ended December 31, 2013, the Fund invested in swap agreements consistent with the Fund’s investment strategies to gain exposure to certain markets or indices.

Warrants: The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish.


Item 2 - Controls and Procedures.

 

(a) The Registrant’s Principal Executive Officer and Principal Financial Officer concluded that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c))) were effective as of a date within 90 days of the filing date of this report (the “Evaluation Date”), based on their evaluation of the effectiveness of the Registrant’s disclosure controls and procedures as of the Evaluation Date.

 

(b) There were no changes in the Registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940 (17 CFR 270.30a-3(d))) that occurred during the Registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

Item 3 – Exhibits.

 

(a) Certification of Principal Executive Officer and Principal Financial Officer of the Registrant as required by Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is attached hereto as EX-99.CERT.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   CLOUGH GLOBAL ALLOCATION FUND
   By:      

/s/ Edmund J. Burke

      Edmund J. Burke
      President (principal executive officer)
   Date:    February 26, 2014

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

   By:      

/s/ Edmund J. Burke

      Edmund J. Burke
      President (principal executive officer)
   Date:    February 26, 2014
   By:      

/s/ Jeremy O. May

      Jeremy O. May
      Treasurer (principal financial officer)
   Date:    February 26, 2014